Hematological Adverse Effects in HCV Patients Treated With Pegylated Interferon and Ribavirin in a Tertiary Care Hospital Peshawar. mfm. 2024;26(3). Accessed February 1, 2026. https://medicalforummonthly.com/index.php/mfm/article/view/2736